Related Experiment Video
Updated: Jul 19, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Specifications of the ACMG/AMP guidelines for ACADVL variant interpretation
May Flowers1, Alexa Dickson2, Marcus J Miller3
1Invitae Corporation, San Francisco, CA 94103, USA.
Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) requires genetic testing due to nonspecific symptoms. An expert panel was formed to standardize ACADVL variant classification for improved diagnosis of this metabolic disorder.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is a common inherited metabolic disorder.
- Accurate diagnosis is challenging due to nonspecific phenotypes and late-onset possibilities.
- Molecular confirmation via ACADVL gene sequencing is crucial for affected status prediction.
Purpose of the Study:
- To address the disparate classification of ACADVL variants.
- To establish standardized guidelines for VLCADD variant interpretation.
- To improve diagnostic accuracy and streamline variant classification.
Main Methods:
- Formation of an ACADVL-specific variant curation expert panel (VCEP).
- Specification of ACMG/AMP guidelines for VLCADD.
- Review and classification of ACADVL gene variants.
Main Results:
- Standardized classification guidelines for ACADVL variants were developed.
- The VCEP aims to improve consistency in variant interpretation.
- Expectation of expedited and more concordant variant classifications.
Conclusions:
- A dedicated VCEP was established to refine variant classification for VLCADD.
- The new guidelines are expected to enhance diagnostic concordance.
- Streamlined classification will expedite the diagnosis of VLCADD.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022